BridgeBio Oncology Therapeutics BBOT
NASDAQ BBOT
$3.92 +0.11 (+2.89%)
At close: Sep 29, 2026 · 4:00 PM EDT

BridgeBio Oncology Therapeutics (BBOT) Securities (2024 - 2026)

Updated

BridgeBio Oncology Therapeutics (BBOT) reported Securities of $290.07 million for Q2 2026, down 13.7% from the prior quarter.

Analysis

BridgeBio Oncology Therapeutics (BBOT) Securities (2024 - 2026) Analysis & Trends

At the end of FY2025, BridgeBio Oncology Therapeutics posted Securities of $51.77 million, down 58.5% from FY2024.

  • By year, Securities came in at $124.78 million in FY2024.
  • Five-year quarterly Securities spans a low of $51.77 million in Q4 2025 and a high of $336.23 million in Q1 2026.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $336.23 million (Q1 2026), $51.77 million (Q4 2025) and $59.54 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Securities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 BridgeBio Oncology Therapeutics 305.24 Mn -1.07 Bn - 290.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 290.07 Mn
Mar 31, 2026 336.23 Mn
Dec 31, 2025 51.77 Mn
Sep 30, 2025 59.54 Mn
Dec 31, 2024 124.78 Mn
API Access

BridgeBio Oncology Therapeutics Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=securities&ticker=BBOT&period=max&api_key=YOUR_API_KEY